IRIDEX CORP
IRIXdata completeness 88%17 fiscal years on fileIRIDEX CORP earns about -255% on invested capital, but has diluted owners by 10% over 5 years — worth asking whether the growth reaches owners. The cash-flow models don't apply cleanly here — the ledger says why below.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2022 | FY 2022 | FY 2023 | FY 2024 | FY 2026 |
|---|---|---|---|---|---|
| Revenue | $53.9M1 | $57M2 | $51.9M3 | $48.7M4 | $52.7M4 |
| Net income | −$5.23M5 | −$7.55M6 | −$9.57M7 | −$8.91M8 | −$4.44M8 |
| Operating cash flow | $8.22M9 | −$9.52M10 | −$6.75M11 | −$7.29M12 | −$2.12M12 |
| Capital expenditure | $213,00013 | $286,00014 | $109,00015 | $13,00016 | $143,00016 |
| Free cash flow (derived) | $8M9 | −$9.81M10 | −$6.85M11 | −$7.3M12 | −$2.26M12 |
| Total debt | — | — | — | $2.7M17 | — |
| Cash & equivalents | $23.9M18 | $13.9M19 | $7.03M20 | $2.39M21 | $6.03M21 |
| Diluted shares | 15.4M | 15.9M | 16.1M | 16.4M | 16.9M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $2.91 of net worth that earned you −$2.62 and generated −$1.33 of cash last year.
It earned an average -255% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 10% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has held roughly steady.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
Different models answer different questions — which to trust when →
- 10-K · period ending 2022-01-01 · accession 0000950170-23-007061 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-038650 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-046107 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-007061 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-038650 (NetIncomeLoss)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-046107 (NetIncomeLoss)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (NetIncomeLoss)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-007061 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-038650 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-046107 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-007061 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-038650 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-046107 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (LongTermDebt)
- 10-K · period ending 2022-01-01 · accession 0000950170-23-007061 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0000950170-24-038650 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-30 · accession 0000950170-25-046107 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-28 · accession 0001193125-26-140194 (CashAndCashEquivalentsAtCarryingValue)